Entrada Therapeutics (TRDA) Assets (2022 - 2025)
Historic Assets for Entrada Therapeutics (TRDA) over the last 4 years, with Q3 2025 value amounting to $412.9 million.
- Entrada Therapeutics' Assets fell 2554.9% to $412.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $412.9 million, marking a year-over-year decrease of 2554.9%. This contributed to the annual value of $526.3 million for FY2024, which is 1217.6% up from last year.
- Per Entrada Therapeutics' latest filing, its Assets stood at $412.9 million for Q3 2025, which was down 2554.9% from $448.8 million recorded in Q2 2025.
- Entrada Therapeutics' 5-year Assets high stood at $582.0 million for Q2 2024, and its period low was $252.1 million during Q4 2022.
- Over the past 4 years, Entrada Therapeutics' median Assets value was $475.6 million (recorded in 2023), while the average stood at $439.0 million.
- Its Assets has fluctuated over the past 5 years, first surged by 8614.59% in 2023, then plummeted by 2554.9% in 2025.
- Quarter analysis of 4 years shows Entrada Therapeutics' Assets stood at $252.1 million in 2022, then surged by 86.15% to $469.2 million in 2023, then increased by 12.18% to $526.3 million in 2024, then decreased by 21.55% to $412.9 million in 2025.
- Its last three reported values are $412.9 million in Q3 2025, $448.8 million for Q2 2025, and $486.5 million during Q1 2025.